FutureChem Co.,Ltd (KOSDAQ:220100)
30,850
-250 (-0.80%)
Dec 30, 2025, 3:30 PM KST
FutureChem Co.,Ltd Revenue
FutureChem Co.,Ltd had revenue of 3.79B KRW in the quarter ending September 30, 2025, a decrease of -9.40%. This brings the company's revenue in the last twelve months to 18.75B, up 19.16% year-over-year. In the year 2024, FutureChem Co.,Ltd had annual revenue of 17.29B with 23.81% growth.
Revenue (ttm)
18.75B
Revenue Growth
+19.16%
P/S Ratio
37.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
696.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.29B | 3.33B | 23.81% |
| Dec 31, 2023 | 13.97B | 1.39B | 11.09% |
| Dec 31, 2022 | 12.57B | 755.26M | 6.39% |
| Dec 31, 2021 | 11.82B | 805.07M | 7.31% |
| Dec 31, 2020 | 11.01B | 2.85B | 34.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.50T |
| Celltrion | 3.90T |
| Yuhan | 2.14T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 675.41B |
| Sam Chun Dang Pharm. | 220.74B |
| ALTEOGEN | 202.18B |
| LigaChem Biosciences | 159.27B |